Cyanotic congenital heart disease (CCHD) with symptomatic erythrocytosis

Journal of General Internal Medicine

Volumn 22, Issue 12, 2007, Pages 1775-1777

  Rose, Shelonitda S ^a   Shah, Ashish A ^a   Hoover, Donald R ^a,b   Saidi, Parvin ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Cyanosis; Erythrocytosis; Hematocrit; Hyperviscosity; Transient ischemic attack (TIA); Venesection

Indexed keywords

IRON; RANITIDINE;

ADULT; AMBIENT AIR; ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD VISCOSITY; BLURRED VISION; CASE REPORT; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CYANOTIC HEART DISEASE; DEHYDRATION; DYSPNEA; ECHOCARDIOGRAPHY; EMERGENCY WARD; ERYTHROCYTOSIS; ERYTHROPOIESIS; FEMALE; HEART ATRIUM SEPTUM DEFECT; HOME OXYGEN THERAPY; HUMAN; HYDRATION; IRON DEFICIENCY; IRON THERAPY; LABORATORY TEST; LEVOCARDIA; LUNG ATRESIA; NEUROLOGIC EXAMINATION; PALLIATIVE THERAPY; PHLEBOTOMY; PHYSICAL EXAMINATION; POLYCYTHEMIA VERA; SYMPTOMATOLOGY; VITAL SIGN;

ADULT; CYANOSIS; FEMALE; HEART DEFECTS, CONGENITAL; HEMATOCRIT; HEMOGLOBINS; HUMANS; IRON; ISCHEMIC ATTACK, TRANSIENT; PHLEBOTOMY; POLYCYTHEMIA; TREATMENT OUTCOME;

EID: 36349003394     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0356-4     Document Type: Article

References (24)

1. Mossuz P, Girodon F, Donnard M, Latger-Cannard V, Dobo I, Boiret N, et al. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis. Haematologica. 2004;89(10):1194-8.
2. Prchal JF, Axelrad AA. Bone-marrow responses in polycythemia vera. N Engl J Med. 1974;290:1382.
3. Warrell DA, Cox TM, Firth JD, Benz EJ. Cyanotic Heart Disease: A Multisystem Disorder. Oxford Textbook of Medicine, 4th edition. London: Oxford University Press; 2003.
4. Territo MC, Rosove MH. Cyanotic congenital heart disease: hematologic management. J Am Coll Cardiol. 1991;18(2):320-2.
5. Murray JF, Gold P, Johnson BL Jr. The circulatory effects of hematocrit variations in normovolemic and hypervolemic dogs. J Clin Invest. 1963;42:1150-9.
6. Kontras SB, Bodenbender JG, Craenen J, Hosier DM. Hyperviscosity in congenital heart disease. J Pediatr. 1970;76:214-20.
7. Replogle RL, Meiselman HJ, Merrill EW. Clinical implications of blood rheology studies. Circulation. 1967;36:148-60.
8. Thorne SA. Management of polycythemia in adults with cyanotic heart disease. Heart. 1998;79:315-6.
9. Pearson TC, Wetherley-Mein G. Vascular occlusive episodes and venous haematocrit in primary proliferative polycythemia. Lancet. 1978;2:1219-22.
10. Messinezy M, Pearson TC, Prochazka A, Wetherley-Mein G. Treatment of primary proliferative polycythaemia by venesection and low dose busulphan: retrospective study from one centre. Br J Haematol. 1985;61:657-66.
11. Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR. Therapeutic recommendations in polycythemia vera based on polycythemia vera study group protocols. Semin Hematol. 1986;23(2):132-43.
12. Oldershaw PJ, Sutton MG. Haemodynamic effects of haematocrit reduction in patients with polycythaemia secondary to cyanotic congenital heart disease. Br Heart J. 1980;44:584-8.
13. Toghi H, Yamanouchi H, Murakami M, Kameyama M. Importance of hematocrit as a risk factor in cerebral infarction. Stroke. 1978;9:369-74.
14. Pearson TC. Rheology of the absolute polycythemias. Baillieres Clin Haematol. 1987;1:637-64.
15. Perloff JK, Marelli AJ, Miner PD. Risk of stroke in adults with cyanotic congenital heart disease. Circulation. 1993;87:1954-9.
16. Ammash N, Warnes CA. Cerbrovascular events in adult patients with cyanotic congenital heart disease. J Am Coll Cardiol. 1996;28:768-72.
17. Cottrill CM, Kaplan S. Cerebral vascular accidents in cyanotic congenital heart disease. Am J Dis Child. 1973;125:484-7.
18. Barabas AP, Offen DN, Meinhard EA. The arterial complications of polycythemia vera. Br J Surg. 1973;60:183-7.
19. Kwaan HC, Wang J. Hyperviscosity in polycythemia vera and other red cell abnormalities. Semin Thromb Hemost. 2003;29:451-8.
20. Ekert H, Gilchrist GS, Stanton R, Hammond D. Hemostasis in cyanotic congenital heart disease. J Pediatr. 1970;76:221-30.
21. Perloff JK, Rosove MH, Child JS, Wright GB. Adults with cyanotic heart disease: hematologic management. Ann Intern Med. 1988;109:406-13.
22. Rosove MH, Perloff JK, Hocking WG, Child JS, Canobbio MM, Skorton DJ. Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet. 1986;2:313-5.
23. Linderkamp O, Klose HJ, Betke K, Brodherr-Heberlein S, Buhlmeyer K, Kelson S, Sengespeik C. Increased blood viscosity in patients with cyanotic heart disease and iron deficiency. J Pediatr. 1979;95:567-9.
24. Rosenthal A, Nathan DG, Marty AT, Button LN, Miettinen OS, Nadas AS. Acute hemodynamic effects of red cell volume reduction in polycythemia of cyanotic congenital heart disease. Circulation. 1970;42:297-308.